The targeted protein degradation enabling technologies market is anticipated to be worth over USD 3.3 billion by 2030
Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare.
London
Roots Analysis has announced the addition of “Targeted Protein Degradation Market” report to its list of offerings.
...
0 Comments
0 Shares